138 related articles for article (PubMed ID: 36583662)
1. Medicinal Chemistry Strategies for the Development of Inhibitors Disrupting β-Catenin's Interactions with Its Nuclear Partners.
Zhang H; Liu C; Zhu D; Zhang Q; Li J
J Med Chem; 2023 Jan; 66(1):1-31. PubMed ID: 36583662
[TBL] [Abstract][Full Text] [Related]
2. 3D-microenvironments initiate TCF4 expression rescuing nuclear β-catenin activity in MCF-7 breast cancer cells.
Sergio S; Coluccia AML; Lemma ED; Spagnolo B; Vergara D; Maffia M; De Vittorio M; Pisanello F
Acta Biomater; 2020 Feb; 103():153-164. PubMed ID: 31843716
[TBL] [Abstract][Full Text] [Related]
3. Parsing β-catenin's cell adhesion and Wnt signaling functions in malignant mammary tumor progression.
Buechel D; Sugiyama N; Rubinstein N; Saxena M; Kalathur RKR; Lüönd F; Vafaizadeh V; Valenta T; Hausmann G; Cantù C; Basler K; Christofori G
Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34408016
[TBL] [Abstract][Full Text] [Related]
4. SOX7 Suppresses Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction.
Fan R; He H; Yao W; Zhu Y; Zhou X; Gui M; Lu J; Xi H; Deng Z; Fan M
DNA Cell Biol; 2018 Feb; 37(2):126-132. PubMed ID: 29271667
[TBL] [Abstract][Full Text] [Related]
5. Direct targeting of β-catenin in the Wnt signaling pathway: Current progress and perspectives.
Wang Z; Li Z; Ji H
Med Res Rev; 2021 Jul; 41(4):2109-2129. PubMed ID: 33475177
[TBL] [Abstract][Full Text] [Related]
6. Wnt/beta-catenin signaling: turning the switch.
Cadigan KM
Dev Cell; 2008 Mar; 14(3):322-3. PubMed ID: 18331712
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 2-(3-(3-Carbamoylpiperidin-1-yl)phenoxy)acetic Acid Derivatives as Novel Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
Wang Z; Zhang M; Luo W; Zhang Y; Ji H
J Med Chem; 2021 May; 64(9):5886-5904. PubMed ID: 33902288
[TBL] [Abstract][Full Text] [Related]
8. LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction.
Li J; Chen X; Ding X; Cheng Y; Zhao B; Lai ZC; Al Hezaimi K; Hakem R; Guan KL; Wang CY
Cell Rep; 2013 Dec; 5(6):1650-63. PubMed ID: 24360964
[TBL] [Abstract][Full Text] [Related]
9. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
10. Recent advances of β-catenin small molecule inhibitors for cancer therapy: Current development and future perspectives.
Yang P; Zhu Y; Zheng Q; Meng S; Wu Y; Shuai W; Sun Q; Wang G
Eur J Med Chem; 2022 Dec; 243():114789. PubMed ID: 36183504
[TBL] [Abstract][Full Text] [Related]
11. Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions.
Brembeck FH; Schwarz-Romond T; Bakkers J; Wilhelm S; Hammerschmidt M; Birchmeier W
Genes Dev; 2004 Sep; 18(18):2225-30. PubMed ID: 15371335
[TBL] [Abstract][Full Text] [Related]
12. The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis.
Vafaizadeh V; Buechel D; Rubinstein N; Kalathur RKR; Bazzani L; Saxena M; Valenta T; Hausmann G; Cantù C; Basler K; Christofori G
Oncogene; 2021 Oct; 40(43):6195-6209. PubMed ID: 34545187
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase A activation enhances β-catenin transcriptional activity through nuclear localization to PML bodies.
Zhang M; Mahoney E; Zuo T; Manchanda PK; Davuluri RV; Kirschner LS
PLoS One; 2014; 9(10):e109523. PubMed ID: 25299576
[TBL] [Abstract][Full Text] [Related]
14. Twa1/Gid8 is a β-catenin nuclear retention factor in Wnt signaling and colorectal tumorigenesis.
Lu Y; Xie S; Zhang W; Zhang C; Gao C; Sun Q; Cai Y; Xu Z; Xiao M; Xu Y; Huang X; Wu X; Liu W; Wang F; Kang Y; Zhou T
Cell Res; 2017 Dec; 27(12):1422-1440. PubMed ID: 28829046
[TBL] [Abstract][Full Text] [Related]
15. Elucidating the interactions between the adhesive and transcriptional functions of beta-catenin in normal and cancerous cells.
van Leeuwen IM; Byrne HM; Jensen OE; King JR
J Theor Biol; 2007 Jul; 247(1):77-102. PubMed ID: 17382967
[TBL] [Abstract][Full Text] [Related]
16. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
17. β-catenin is O-GlcNAc glycosylated at Serine 23: implications for β-catenin's subcellular localization and transactivator function.
Ha JR; Hao L; Venkateswaran G; Huang YH; Garcia E; Persad S
Exp Cell Res; 2014 Feb; 321(2):153-66. PubMed ID: 24342833
[TBL] [Abstract][Full Text] [Related]
18. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.
Yan M; Li G; An J
Exp Biol Med (Maywood); 2017 Jun; 242(11):1185-1197. PubMed ID: 28474989
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
[TBL] [Abstract][Full Text] [Related]
20. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
